Trial intelligence / Profile preview

Caffeine for fast-track extubation and cognitive outcomes in children undergoing open heart surgery

PACTR202308786657562Recruiting

Sponsor
Mansoura University Children Hospital
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Cardiovascular Malformation (CVM) comparing caffeine group with control placebo group (2 arms). Primary endpoint: Extubation time. Started Aug 2023; status: recruiting.

02

Drugs

caffeine
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on PACTR202308786657562.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202308786657562.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call